CTRI/2023/10/058943尚未招募4 期
Prospective Analysis of safety, effectiveness and compliance of EPO (erythropoietin) therapy by using WEPOX® Dispopen 20,000 IU in the management of CKD Anemia - nil
Wockhardt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Adult patient (age 18-75 years) of any gender.
- •2. Patients newly prescribed with WEPOX Dispopen 20000 IU for anemia due to chronic kidney disease (CKD).
- •3. Patient willing to comply with the protocol and written Informed Consent.
排除标准
- •1.Patients who do not meet requirement as per prescribing information of WEPOX Dispopen 20000 IU
- •2.Pregnant and lactating females
研究者
相似试验
尚未招募
4 期
Study to Analyze safety, effectiveness and compliance of erythropoietin therapy using WEPOX® Dispopen, A new delivery device, in the management of CKD AnemiaCTRI/2022/07/043917Wockhardt Ltd
招募中
不适用
A prospective analysis of the efficacy and safety of complete surgery for advanced ovarian, fallopian tubal, primary peritneal cancerJPRN-UMIN000022284School of Medicine, Chiba University100
尚未招募
不适用
A Prospective study of the Safety and Effectiveness of Uterine Artery Embolization for the treatment of Endometriosis (UAE-E) – a Pilot StudyReproductive Health and Childbirth - Other reproductive health and childbirth disordersEndometriosisACTRN12622001301752The Alfred Hospital6
招募中
不适用
Retrospective analysis of safety and effectiveness of recombinant thrombomodulin for vascular endothelial syndrome after hematopoietic cell transplantation in children.Pediatric patients who developed vascular endothelial syndrome after hematopoietc cell transplantation.JPRN-UMIN000022640Yokohama City University30
招募中
不适用
Prospective evaluation of the safety and efficacy of MR-guided single-fraction stereotactic ablative radiotherapy for unresectable primary or secondary liver tumors - SINGLE SHOT LIVERC22C78.7Malignant neoplasm of liver and intrahepatic bile ductsSecondary malignant neoplasm of liver and intrahepatic bile ductDRKS00027117Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum Grosshadern der LMU München35